This grant is for research on new treatments for adult glioblastoma, a type of brain cancer. The goal is to develop drugs that can cross the blood-brain barrier and test them in early-stage clinical trials. The grant supports a network of teams working together to move drugs from pre-clinical research to human trials.
Who it's for: This grant is for organizations and individuals involved in medical research, especially those focused on developing new treatments for glioblastoma. Eligible applicants include various types of nonprofits, educational institutions, tribal organizations, for-profit organizations, and government entities.
More details
Likely Disqualifiers
- Lack of experience in drug development for glioblastoma
- Inability to conduct clinical trials
- Proposals not focused on adult glioblastoma
- Lack of collaboration with other research teams
- Inability to demonstrate drug's ability to cross the blood-brain barrier
What You May Need
- Detailed research proposal
- Evidence of collaboration with other research teams
- Pre-clinical study results
- Plan for clinical trials
- Budget proposal
- Organizational capability statement
- Proof of eligibility
- Registration with relevant federal systems (e.g., SAM.gov)
- Letters of support or partnership agreements
- Compliance with human subjects research regulations
Cautions
- Ensure drugs can cross the blood-brain barrier
- Focus on adult glioblastoma only
- Collaboration with other teams is crucial
- Must comply with clinical trial regulations
- Funding is competitive and limited
Generated from official source details for readability
Eligibility
Eligible Applicant Types
Additional Criteria
Eligible applicants include nonprofits with and without 501(c)(3) status, public and state institutions of higher education, other Native American tribal organizations, for-profit organizations, federally recognized Indian tribal governments, private institutions of higher education, special district governments, state governments, individuals, county governments, city or township governments, independent school districts, and entities with unrestricted eligibility.
Overview
This grant is for organizations and individuals involved in medical research, especially those focused on developing new treatments for glioblastoma. Eligible applicants include various types of nonprofits, educational institutions, tribal organizations, for-profit organizations, and government entities.
Likely Disqualifiers
- Lack of experience in drug development for glioblastoma
- Inability to conduct clinical trials
- Proposals not focused on adult glioblastoma
- Lack of collaboration with other research teams
- Inability to demonstrate drug's ability to cross the blood-brain barrier
Use of Funds
Funds can be used for research and development of new glioblastoma treatments, including pre-clinical studies and early-stage clinical trials. This includes costs related to drug development, testing, and collaboration among research teams.
Total Program Funding
$4,400,000
Expected Awards
4
Cost Sharing
Not Required
Important Dates
- Posted
- Aug 31, 2026
- Deadline
- Oct 1, 2026(19 days)
- Archive Date
- Nov 30, 2026
- Est. Award Date (AI estimate)
- Winter 2026
Application Checklist
- Register with federal systems (e.g., SAM.gov)
- Prepare a detailed research proposal
- Gather pre-clinical study data
- Develop a clinical trial plan
- Create a budget proposal
- Compile organizational capability documents
- Obtain letters of support or partnership agreements
- Ensure compliance with human subjects research regulations
- Submit application by the deadline